In mouse melanoma and mouse and human ovarian cancer, it has been shown that blocking the PD-L1/PD-1 axis via anti-PD1 or anti-PD-L1 antibodies can trigger autophagy in tumor cells, and when coupled with autophagy inhibitors, enhance the response [40]. The gene discussed is CD274; the disease is melanoma.